Table 2.
All Subjects |
African American |
European American |
Pint† | ||||
---|---|---|---|---|---|---|---|
OR* | 95% CI | OR* | 95% CI | OR* | 95% CI | ||
Age at enrollment, yr | 1.02 | 1.02–1.03 | 1.03 | 1.03–1.04 | 1.02 | 1.01–1.03 | 1.000 |
Race/ethnicity, African American | 2.95 | 2.61–3.34 | — | — | — | — | — |
Sex, female | 1.61 | 1.43–1.82 | 1.64 | 1.43–1.89 | 1.91 | 1.30–2.00 | 0.940 |
Height, m | 0.22 | 0.13–0.40 | 0.32 | 0.16–0.64 | 0.23 | 0.08–0.68 | 0.620 |
BMI, kg/m2 | 1.04 | 1.03–1.05 | 1.03 | 1.02–1.03 | 1.05 | 1.04–1.07 | <0.001 |
Smoking, ever smoker | 2.51 | 2.22–2.83 | 2.71 | 2.32–3.16 | 2.00 | 1.60–2.51 | 0.028 |
Age at diagnosis, yr | 1.01 | 1.00–1.01 | 1.01 | 1.01–1.02 | 1.01 | 1.00–1.02 | 0.230 |
Age at diagnosis > 12 yr | 1.28 | 1.15–1.44 | 1.49 | 1.29–1.71 | 1.31 | 1.06–1.61 | 0.378 |
Ever hospitalized, yes | 2.22 | 1.98–2.49 | 1.78 | 1.55–2.04 | 2.17 | 1.73–2.73 | 0.142 |
FEV1, L | 0.47 | 0.43–0.50 | 0.52 | 0.48–0.57 | 0.54 | 0.47–0.62 | 0.668 |
FVC, L | 0.60 | 0.57–0.64 | 0.68 | 0.63–0.73 | 0.67 | 0.60–0.75 | 0.917 |
FEV1/FVC ratio | 0.96 | 0.95–0.96 | 0.96 | 0.95–0.97 | 0.97 | 0.96–0.98 | 0.164 |
Bronchodilator reversibility | 1.03 | 1.03–1.04 | 1.03 | 1.02–1.03 | 1.05 | 1.04–1.06 | 0.002 |
Definition of abbreviations: BMI = body mass index; CI = confidence interval; OR = odds ratio; Pint = P value from a 1 degree of freedom likelihood ratio test of the multiplicative interaction between self-reported race/ethnicity and each variable.
The outcome variable for the association analyses was nocturnal asthma defined as having any night with disrupted sleep due to asthma in the preceding 4 weeks.
ORs represent the univariable relationship with nocturnal asthma. These estimates reflect the effect of a one-unit increase in the variable of interest.
The P value for the likelihood ratio test of interaction between race/ethnicity and each variable in a bivariable model, which includes a covariate for self-reported race/ethnicity.